Literature DB >> 28665681

Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.

Pennan M Barry1, Phil Lowenthal1, Lisa True1, Leslie Henry1, Gayle Schack1, Kristen Wendorf1, Jennifer Flood1, Neha Shah1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28665681     DOI： 10.1164/rccm.201701-0013LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

1.  Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011-2016.

Authors:  Clarisse A Tsang; Neha Shah; Lori R Armstrong; Suzanne M Marks
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

Review 3.  New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.

Authors:  Denise Rossato Silva; Margareth Dalcolmo; Simon Tiberi; Marcos Abdo Arbex; Marcela Munoz-Torrico; Raquel Duarte; Lia D'Ambrosio; Dina Visca; Adrian Rendon; Mina Gaga; Alimuddin Zumla; Giovanni Battista Migliori
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.